VMY-1-103
VMY-1-103 is an inhibitor for cyclin/Cdk complex, that arrests the cell cycle at G1 phase. VMY-1-103 reduces mitochondrial membrane potential, induces p53 phosphorylation and and PARP cleavage, activates caspase-3, and thus induces apoptosis in prostate cancer cell LNCaP.
For research use only. We do not sell to patients.
- CAS No.: 1209002-43-6
- Formula: C34H42ClN9O4S
- Molecular Weight:708.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF7 | IC50 |
10.03 μM
Compound: VMY-1-103
|
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by WST-1 assay
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by WST-1 assay
|
[PMID: 21440449] |
| MCF7 | IC50 |
4.5 μM
Compound: VMY-1-103
|
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 72 hrs by WST-1 assay
Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 72 hrs by WST-1 assay
|
[PMID: 21440449] |
| MDA-MB-231 | IC50 |
4.06 μM
Compound: VMY-1-103
|
Antiproliferative activity against estrogen receptor-deficient human MDA-MB-231 cells after 48 hrs by WST-1 assay
Antiproliferative activity against estrogen receptor-deficient human MDA-MB-231 cells after 48 hrs by WST-1 assay
|
[PMID: 21440449] |
Chemical Information
-
CAS No. 1209002-43-6
-
Molecular Weight 708.27
-
Formula C34H42ClN9O4S
-
SMILES
O=C(NCCNS(=O)(C1=C2C=CC=C(N(C)C)C2=CC=C1)=O)C3=CC=C(NC4=C5N=CN(C(C)C)C5=NC(N[C@@H](CO)C(C)C)=N4)C=C3Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)